Publications by authors named "M A Varney"

Claim this Profile
O
Optimization of (Dithioperoxo)thiolate-Based Antifungal Agents for Triazole-Resistant .
Surya Karuturi, Kaitlyn L Jobe, Melinda E Varney, Michael D Hambuchen, A R M Ruhul Amin

Pathogens· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA binding proteins PCBP1 and PCBP2 regulate pancreatic β cell translation.
Matthew W Haemmerle, Kirill Batmanov, Sabyasachi Sen, Matthew J Varney, Alexander T Utecht

Mol Metab· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NLX-112 Randomized Phase 2A Trial: Safety, Tolerability, Anti-Dyskinetic, and Anti-Parkinsonian Efficacy.
Per Svenningsson, Per Odin, Filip Bergquist, Karin Wirdefeldt, Dag Nyholm, Mark A Varney

Mov Disord· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rescue of respiratory and cognitive impairments in Rett Syndrome mice using NLX-101, a selective 5-HT receptor biased agonist.
Daniela Monteiro-Fernandes, Ian Charles, Sara Guerreiro, Daniela Cunha-Garcia, Joana Pereira-Sousa, Mark A Varney

Biomed Pharmacother· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute administration of NLX-101, a Serotonin 1A receptor agonist, improves auditory temporal processing during development in a mouse model of Fragile X Syndrome.
Xin Tao, Katilynne Croom, Adrian Newman-Tancredi, Mark Varney, Khaleel A Razak

J Neurodev Disord· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis